166 related articles for article (PubMed ID: 16611096)
1. Alcoholism and neuropeptides: an update.
Cowen MS; Lawrence AJ
CNS Neurol Disord Drug Targets; 2006 Apr; 5(2):233-9. PubMed ID: 16611096
[TBL] [Abstract][Full Text] [Related]
2. Targeting NPY, CRF/UCNs and NPS Neuropeptide Systems to Treat Alcohol Use Disorder (AUD).
Rodriguez FD; Coveñas R
Curr Med Chem; 2017; 24(23):2528-2558. PubMed ID: 28302012
[TBL] [Abstract][Full Text] [Related]
3. Pre-clinical evidence that corticotropin-releasing factor (CRF) receptor antagonists are promising targets for pharmacological treatment of alcoholism.
Lowery EG; Thiele TE
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):77-86. PubMed ID: 20201818
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptides: implications for alcoholism.
Cowen MS; Chen F; Lawrence AJ
J Neurochem; 2004 Apr; 89(2):273-85. PubMed ID: 15056272
[TBL] [Abstract][Full Text] [Related]
5. [Role of endogenous neuropeptides in the pathomechanism of alcohol addiction].
Rudzińska U; Zalewska-Kaszubska J
Postepy Hig Med Dosw (Online); 2009 Dec; 63():643-52. PubMed ID: 20097951
[TBL] [Abstract][Full Text] [Related]
6. Allostasis and dysregulation of corticotropin-releasing factor and neuropeptide Y systems: implications for the development of alcoholism.
Valdez GR; Koob GF
Pharmacol Biochem Behav; 2004 Dec; 79(4):671-89. PubMed ID: 15582675
[TBL] [Abstract][Full Text] [Related]
7. Alcoholism and obesity: overlapping neuropeptide pathways?
Thiele TE; Navarro M; Sparta DR; Fee JR; Knapp DJ; Cubero I
Neuropeptides; 2003 Dec; 37(6):321-37. PubMed ID: 14698675
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms.
Heilig M; Egli M
Pharmacol Ther; 2006 Sep; 111(3):855-76. PubMed ID: 16545872
[TBL] [Abstract][Full Text] [Related]
9. Stress-related neuropeptides and alcoholism: CRH, NPY, and beyond.
Ciccocioppo R; Gehlert DR; Ryabinin A; Kaur S; Cippitelli A; Thorsell A; Lê AD; Hipskind PA; Hamdouchi C; Lu J; Hembre EJ; Cramer J; Song M; McKinzie D; Morin M; Economidou D; Stopponi S; Cannella N; Braconi S; Kallupi M; de Guglielmo G; Massi M; George DT; Gilman J; Hersh J; Tauscher JT; Hunt SP; Hommer D; Heilig M
Alcohol; 2009 Nov; 43(7):491-8. PubMed ID: 19913192
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic mechanisms of alcoholism and stress-related disorders.
Palmisano M; Pandey SC
Alcohol; 2017 May; 60():7-18. PubMed ID: 28477725
[TBL] [Abstract][Full Text] [Related]
11. Neuropharmacology of alcohol addiction.
Vengeliene V; Bilbao A; Molander A; Spanagel R
Br J Pharmacol; 2008 May; 154(2):299-315. PubMed ID: 18311194
[TBL] [Abstract][Full Text] [Related]
12. Therapeutics for alcoholism: what's the future?
Lawrence AJ
Drug Alcohol Rev; 2007 Jan; 26(1):3-8. PubMed ID: 17364830
[TBL] [Abstract][Full Text] [Related]
13. The central amygdala and alcohol: role of γ-aminobutyric acid, glutamate, and neuropeptides.
Roberto M; Gilpin NW; Siggins GR
Cold Spring Harb Perspect Med; 2012 Dec; 2(12):a012195. PubMed ID: 23085848
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.
Hallberg M
Med Res Rev; 2015 May; 35(3):464-519. PubMed ID: 24894913
[TBL] [Abstract][Full Text] [Related]
15. Stress-related neuropeptide systems as targets for treatment of alcohol addiction: A clinical perspective.
Heilig M
J Intern Med; 2023 May; 293(5):559-573. PubMed ID: 37052145
[TBL] [Abstract][Full Text] [Related]
16. The nociceptin/orphanin FQ system as a target for treating alcoholism.
Murphy NP
CNS Neurol Disord Drug Targets; 2010 Mar; 9(1):87-93. PubMed ID: 20201819
[TBL] [Abstract][Full Text] [Related]
17. Neurocircuitry of alcohol addiction: synthesis from animal models.
Koob GF
Handb Clin Neurol; 2014; 125():33-54. PubMed ID: 25307567
[TBL] [Abstract][Full Text] [Related]
18. The Role of the Central Amygdala in Alcohol Dependence.
Roberto M; Kirson D; Khom S
Cold Spring Harb Perspect Med; 2021 Feb; 11(2):. PubMed ID: 31988201
[TBL] [Abstract][Full Text] [Related]
19. Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism.
Zorrilla EP; Heilig M; de Wit H; Shaham Y
Drug Alcohol Depend; 2013 Mar; 128(3):175-86. PubMed ID: 23294766
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide systems and new treatments for nicotine addiction.
Bruijnzeel AW
Psychopharmacology (Berl); 2017 May; 234(9-10):1419-1437. PubMed ID: 28028605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
